China Nepstar CEO resigns; Myanmar turns to India as drug spending grows;

> China drug store chain Nepstar ($NPD) said Fuxiang Zhang has resigned as CEO for personal reasons and Rebecca Yingnan Zhang has been appointed in his place. Release

> Myanmar increasingly relies on drugs from India as spending, both private and aid-funded public programs, gain traction, according to the Myanmar Times. Report

> China's spending on medical assistance subsidies nationwide reached more than 100 billion yuan ($16 billion) in the past 6 years, but social welfare programs need to expand further, according to the ministry of finance. Release

> India's Ananth Kumar, responsible for drug policy, repeated a pledge to provide essential medicines at 40% to 60% less than current prices through state-run medical stores. Report